Andrew Prentice of the Medical Research Council in the United Kingdom will conduct a phase II clinical trial to test the ability of a unique nano iron compound to safely and more effectively treat iron-deficiency anemia in children. Iron-deficiency anemia is a common condition particularly in women and children in resource-poor settings and can be deadly. Current iron supplements have limited effects in these settings and undesirable side effects including increasing the risk of infectious diarrhea in children which causes severe morbidity and mortality. They previously developed a compound iron hydroxide adipate tartrate that acts like dietary iron as it can be directly absorbed in humans keeping it away from any resident intestinal pathogens that also use it as a nutrient source. They will perform an intervention study with 600 iron-deficient anemic children in The Gambia and compare their compound with the current supplement to see if it can normalize iron levels without the side effects.

Thokozani Mwenyekonde from CARE in Malawi is implementing the Umodzi project to promote gender equality for women and girls by engaging adolescent girls and boys, along with supportive adult male and female role models, to integrate gender equitable attitudes and behavior in schools as a basis for changing attitudes nationwide. Umodzi, which means "oneness" in the local Chichewa language, will build upon and adapt existing gender equality approaches including integrating efforts into the school curriculum, training teachers who convene teen club meetings, and working with adults who are also engaged in CARE's pro-women agriculture and savings programs in the school catchment areas.

Michael Tyers of the University of Montreal in Canada will develop a synthetic biology platform to generate vast libraries of natural product-like compounds and use them to identify new drugs for tuberculosis. Traditional drug discovery screens require expensive chemical libraries that are limited in size and scope. Many existing drugs are derived from the natural products of microbes which perform a wide variety of biological functions. This functional diversity is reflected by their structural diversity which is generated by the combinatorial action of hundreds of thousands of different enzymes. They will exploit this natural manufacturing process for the relatively simple and low-cost production of millions to billions of chemically-diverse natural product-like compounds. This will be achieved by expressing different combinations of the enzymes in yeast artificial chromosomes which then allows screening directly in the yeast without the need for costly and time-consuming chemical extraction and purification. Using this approach they will perform a pilot screen to identify new compounds that inhibit the growth of the bacterium that causes tuberculosis.